Affordable Access

Reduced Immune Response and Neutralizing Antibody Activity to the SARS-CoV-2 Vaccination in Patients with a History of Solid Organ Transplant.

Authors
  • French, Deborah
  • Ong, Chui Mei
  • Patel, Paul
  • Zuk, Marisa
  • Wu, Alan HB
Publication Date
Sep 01, 2022
Source
eScholarship - University of California
Keywords
License
Unknown
External links

Abstract

ObjectiveThree SARS-CoV-2 vaccinations and boosters are available. We determined whether solid organ transplant patients mounted an immune response to the vaccinations and whether the antibodies had neutralizing activity compared to healthcare worker controls and monoclonal gammopathy patients.MethodsRemnant plasma was obtained from vaccinated solid organ transplant, allogeneic stem cell transplant, monoclonal gammopathy patients, and healthcare worker controls. Samples positive on a SARS-CoV-2 IgG assay (detects spike protein and nucleocapsid) were run on a SARS-CoV-2 in vitro neutralizing antibody assay and a nucleocapsid-specific SARS-CoV-2 IgG assay.ResultsOnly 25% of solid organ transplant patients produced antibodies to SARS-CoV-2 vaccination. Of these, 90% had neutralizing activity against wild type virus, but reduced activity to the variants compared to monoclonal gammopathy patients and healthcare worker controls, particularly the delta variant, for which only 50% had neutralizing antibody activity.ConclusionSolid organ transplant patients should consider protecting themselves against future SARS-CoV-2 infection.

Report this publication

Statistics

Seen <100 times